Triple

Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).

Phrase: Vitrakvi | Statement: [Loxo Oncology, leadProductMarketedName, Vitrakvi]

Target entity: Vitrakvi
Context triple: [Loxo Oncology, leadProductMarketedName, Vitrakvi]

• A. Biktarvy
  Biktarvy is a prescription combination antiretroviral medication used to treat HIV-1 infection in adults and certain children.
• B. Darzalex
  Darzalex is a monoclonal antibody drug (daratumumab) used primarily in the treatment of multiple myeloma.
• C. Verzenio
  Verzenio is a prescription cancer medication (abemaciclib) used primarily to treat certain types of hormone receptor–positive, HER2-negative breast cancer.
• D. Vumerity
  Vumerity is an oral prescription medication used to treat relapsing forms of multiple sclerosis in adults.
• E. Anpezan
  Anpezan is a regional dialect of the Ladin language spoken in parts of the Dolomite area of northern Italy.
• F. None of above. chosen
• G. Unsure - the case is ambiguous/there is not enough information to decide.

Generate a one-sentence description of the target entity. 
You are given a context triple in the form (subject, predicate, object), where the object is the target entity. 
# Instructions
Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. 
Avoid repeating the information from the triple, unless really essential.
# Response Format
Return only the sentence: "Description: [one-sentence description of the target entity]"

Entity: Vitrakvi
Triple: [Loxo Oncology, leadProductMarketedName, Vitrakvi]

Vitrakvi is a targeted cancer therapy (larotrectinib) used to treat solid tumors that have a specific NTRK gene fusion, regardless of the tumor’s location in the body.

Target entity: Vitrakvi
Target entity description: Vitrakvi is a targeted cancer therapy (larotrectinib) used to treat solid tumors that have a specific NTRK gene fusion, regardless of the tumor’s location in the body.

• A. Biktarvy
  Biktarvy is a prescription combination antiretroviral medication used to treat HIV-1 infection in adults and certain children.
• B. Darzalex
  Darzalex is a monoclonal antibody drug (daratumumab) used primarily in the treatment of multiple myeloma.
• C. Verzenio
  Verzenio is a prescription cancer medication (abemaciclib) used primarily to treat certain types of hormone receptor–positive, HER2-negative breast cancer.
• D. Vumerity
  Vumerity is an oral prescription medication used to treat relapsing forms of multiple sclerosis in adults.
• E. Anpezan
  Anpezan is a regional dialect of the Ladin language spoken in parts of the Dolomite area of northern Italy.
• F. None of above. chosen

Target predicate: leadProductMarketedName
Context triple: [Loxo Oncology, leadProductMarketedName, Vitrakvi]

• A. marketingNameOf chosen
  Indicates that one entity is the marketing or brand name used to promote or refer to another entity.
• B. tradeNameIncludes
  Indicates that a trade name contains another name or term as part of its full designation.
• C. originalMarketingName
  Indicates the original marketing or brand name under which an entity (such as a product or service) was first promoted or sold.
• D. sponsorDrugBrand
  Indicates that one entity financially supports, endorses, or promotes a specific drug brand, typically in a commercial or regulatory context.
• E. drugGenericName
  Indicates that a drug entity is associated with its generic (non-brand) name.
• F. None of above.